Next-Gen Sequencing and Proviral DNA: The Future of HIV Drug Resistance Testing?

Webinar Main Objectives:

  1. Update on recent technological advances in genotypic HIV Resistance testing
  2. Review of the clinical relevance of low-frequency resistance mutations detected by Next-Generation Sequencing (NGS)
  3. Discuss the potential benefits and limitations of proviral DNA-based HIV resistance testing

The webinar will be presented by:

Dr. Chanson Brumme
Assistant Director, Research Laboratories
BC Centre for Excellence in HIV/AIDS

The presentation will be followed by a question and answer period where participants will have the opportunity to ask questions and receive real time responses from the presenter.

Cost: Free registration.

Please register for the webinar by

clicking here.

This event will be accredited.

If you are unable to attend the live webinar it will be recorded and available for viewing on BC-CfE’s Education and Training website at: education.cfenet.ubc.ca/webinars.

For questions related to this event please contact: education@cfenet.ubc.ca


Event Details

Days
Hours
Minutes
Seconds
Start Date
  • September 23, 2020 12:00
End Date
  • September 23, 2020 13:00
Email
education@bccfe.ca
Event Category
  • Learning Series
Calendar of Events
Click here for the Calendar of Events
Attendees of the BC-CfE Learning Series will be able to:
  • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
  • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
  • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
  • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search